Literature DB >> 10901155

Brain noradrenaline and the mechanisms of action of antidepressant drugs.

T H Svensson1.   

Abstract

The basic mechanisms of action of presently used antidepressant drugs are still far from understood. This review will address a few critical issues in this area, namely (i) putative mechanisms underlying the delay in onset of action of monoamine reuptake inhibitors and potential limitations to the efficacy of these drugs, (ii) the significance of stress-induced activation of the locus coeruleus noradrenergic system for the function of the mesolimbic reward system and the effect of chronic antidepressant treatment within this context and (iii) the interaction between brain noradrenaline and 5-hydroxytryptamine systems and its significance for antidepressant drug action. Recent preclinical and clinical research which suggest novel strategies to enhance antidepressant drug efficacy will also be discussed. From this review emerges the notion that facilitation of brain noradrenergic neurotransmission may represent a more fundamental means to achieve maximal response in major depression than hitherto understood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901155     DOI: 10.1034/j.1600-0447.2000.02604.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  8 in total

1.  Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.

Authors:  Jose A Morón; Alicia Brockington; Roy A Wise; Beatriz A Rocha; Bruce T Hope
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model.

Authors:  Horrick Sharma; Soumava Santra; Joy Debnath; Tamara Antonio; Maarten Reith; Aloke Dutta
Journal:  Bioorg Med Chem       Date:  2013-11-19       Impact factor: 3.641

Review 3.  Neurotransmitter transporters and their impact on the development of psychopharmacology.

Authors:  Leslie Iversen
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder.

Authors:  Mary Ann Richardson; Laura L Read; Margaret A Reilly; James D Clelland; Catherine L Taylor Clelland
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

Review 5.  Depression and osteoporosis: epidemiology and potential mediating pathways.

Authors:  B Mezuk; W W Eaton; S H Golden
Journal:  Osteoporos Int       Date:  2007-09-01       Impact factor: 4.507

6.  Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain.

Authors:  Yukie Kawahara; Hiroshi Kawahara; Fumi Kaneko; Masatoshi Tanaka
Journal:  Psychopharmacology (Berl)       Date:  2007-05-30       Impact factor: 4.530

Review 7.  Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities.

Authors:  Paul J Fitzgerald; Pho J Hale; Anjesh Ghimire; Brendon O Watson
Journal:  Front Behav Neurosci       Date:  2021-01-14       Impact factor: 3.558

8.  Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.

Authors:  Erik G Jönsson; Jessica Bah; Jonas Melke; Rami Abou Jamra; Johannes Schumacher; Lars Westberg; Roland Ivo; Sven Cichon; Peter Propping; Markus M Nöthen; Elias Eriksson; Göran C Sedvall
Journal:  BMC Psychiatry       Date:  2004-03-04       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.